Low Concentration Ozone for Surface Disinfection against Sars-Cov-2 and Feline Coronavirus

Intro: Surface and environment disinfection is an important part of infection control strategies, especially in the ongoing COVID-19 pandemic. Ozone, a highly reactive oxidant, is a widely used disinfectant in many industries including food, healthcare and water treatment. It has a broad-spectrum activity and leaves no harmful residues. However, most demonstrated efficacy has been at high ozone levels (>1ppm) which can be harmful to humans in case of exposure. Here, we undertook a study to evaluate if exposure to ozone is effective in inactivating SARS-CoV-2 and feline coronavirus (FCoV) even at low concentrations. Method(s): Ozone at 0.07, 0.1 and 1.2 ppm were evaluated for its virucidal activity against SARS-CoV-2 and FCoV. An ozone gas generator (Medklinn Air + Surface Sterilizer (CerafusionTM Technology), Medklinn, Malaysia) supplied controlled levels of ozone to a custom-built chamber of 1.5 ft3 (1.5ft x 1ft x 1ft) where dry virus films containing 1 x 104 PFU of test virus were exposed to ozone gas for 0.5h, 1h, 3h, 5h, and 8h. The experiment was performed at ambient temperature (23-24oC) and relative humidity (RH) of 55% (FCoV only) and 85% (SARS-CoV-2 and FCoV). Finding(s): At low level of ozone of 0.1ppm, >90% reduction of both viruses was achieved after 3h exposure at 85% and 55% humidity. At 1.2ppm, >90% reduction of both viruses was achieved after 0.5h exposure at 85% humidity. Ozone at 0.07ppm, however, did not show good efficacy as reduction not exceeding 90% was achieved only after 8h exposure at 85% and 55% humidity. Conclusion(s): The study demonstrated that low concentration of ozone of at least 0.1 ppm reduced SARS-CoV-2 and FCoV by >90% when used at 85% humidity. The use of low level ozone presents a safer alternative for disinfecting enclosed spaces and greatly reduces any potential harmful health effects in case of accidental exposure.Copyright © 2023

Effect of the COVID-19 pandemic on blood donations and transfusions in Nigeria - A multi-facility study of 34 tertiary hospitals.

Background: The coronavirus disease 2019 (COVID-19) pandemic affected blood supplies globally. Mobile blood drive campaigns halted, and voluntary blood donations reduced, challenging available blood supplies. Furthermore, fears of virus transmission led to deferrals of elective surgeries and non-urgent clinical procedures with noticeable declines in blood donations and transfusions. Aims: We aimed to assess the effect of the COVID-19 pandemic on the number of blood donations and transfusions across the country by blood product type across various hospital departments. Materials and Methods: A retrospective descriptive study was conducted to determine the impact of the COVID-19 pandemic on blood services in 34 tertiary hospitals in Nigeria, comparing January to July 2019 (pre-COVID-19) to January to July 2020 (peri-COVID-19). Data were collected from the country's web-based software District Health Information System, Version 2 (DHIS2). Results: A 17.1% decline in numbers of blood donations was observed over the study period, especially in April 2020 (44.3%), a 21.7% decline in numbers of blood transfusions, especially in April 2020 (44.3%). The largest declines in transfusion were noted in surgery department for fresh frozen plasma (80.1%) [p = 0.012] and accident and emergency department transfusion of platelets (78.3%) [p = 0.005]. The least decline of statistical significance was observed in internal medicine transfusions of whole blood (19.6%) [p = 0.011]. Conclusions: The COVID-19 pandemic significantly affected the numbers of blood donations and transfusions in Nigeria. Strengthening blood services to provide various blood components and secure safe blood supplies during public health emergencies is therefore critical.

COVID-19 operational disruption and SMEs' performance: the moderating role of disruption orientation and government support

Purpose Despite the growing unforeseen and catastrophic events that disrupt business operations, empirical studies on the impact of operational disruption (OD) on small and medium enterprises' (SMEs) performance dimensions are limited. The study aims to investigate the moderating effect of disruption orientation (DO) and government support (GS) on the relationship between coronavirus disease (COVID-19) OD and SMEs' performance. Design/methodology/approach Quantitative survey method was used to collect data from 170 SMEs in Nigeria, through hand-delivery questionnaires. Partial least square (PLS) structural equation modeling (SEM) was employed to analyze the data. Findings The result shows no significant relationship between COVID-19 OD, DO and GS with SMEs' financial performance (FP). However, the relationship between COVID-19 OD and non-financial performance (NFP) is negatively significant. The relationship between DO and NFP is positively significant. DO and GS have insignificant relationship with FP. Finally, DO and GS does not moderate any of the relationships between COVID-19 OD and the dimensions of SMEs' performance. Practical implications The result implies that health-related disruptions such as COVID-19 affect only the NFP of SMEs. However, supply chain managers and SMEs are encouraged to adopt DO to enhance NFP of firms. Originality/value The current study is the first to evaluate the impact of health-related disruptions on the two major dimensions of SMEs' performance (FP and NFP) by incorporating the moderating role of internal (DO) and external (GS) factors in to a single framework. However, the paper revealed new theoretical and practical knowledge by illuminating the absence of significant relationship between COVID-19 OD and SMEs' FP, implying that COVID-19 disruption does not significantly affect SMEs' FP.

Multiplex sequencing of SARS-Cov-2 genome directly from clinical samples using the Ion Personal Genome Machine (PGM).

Various methods have been developed for rapid and high throughput full genome sequencing of SARS-CoV-2. Here, we described a protocol for targeted multiplex full genome sequencing of SARS-CoV-2 genomic RNA directly extracted from human nasopharyngeal swabs using the Ion Personal Genome Machine (PGM). This protocol involves concomitant amplification of 237 gene fragments encompassing the SARS-CoV-2 genome to increase the abundance and yield of viral specific sequencing reads. Five complete and one near-complete genome sequences of SARS-CoV-2 were generated with a single Ion PGM sequencing run. The sequence coverage analysis revealed two amplicons (positions 13 751-13 965 and 23 941-24 106), which consistently gave low sequencing read coverage in all isolates except 4Apr20-64- Hu. We analyzed the potential primer binding sites within these low covered regions and noted that the 4Apr20-64-Hu possess C at positions 13 730 and 23 929, whereas the other isolates possess T at these positions. The genome nucleotide variations observed suggest that the naturally occurring variations present in the actively circulating SARS-CoV-2 strains affected the performance of the target enrichment panel of the Ion AmpliSeq™ SARS CoV 2 Research Panel. The possible impact of other genome nucleotide variations warrants further investigation, and an improved version of the Ion AmpliSeq™ SARS CoV 2 Research Panel, hence, should be considered.